SLXP Financials 07/21/2014 23:37:25
Salix Pharmaceuticals, Ltd.
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue 933,838 735,444 540,488 336,973
Cost of Revenue 179,392 124,597 95,369 68,677
Gross Profit 754,446 610,847 445,119 268,296
Operating Expenses
Research and Development 149,974 123,234 104,350 73,346
Sales, General and Admin. 288,015 228,589 213,988 156,101
Non-Recurring Items - 41,600 - 34,656
Other 44,744 45,351 10,908 10,370
Operating Income 271,713 172,073 115,873 (6,177)
Income From Continuing Operations
Add'l Income/Expense Items 2,003 (4,727) 2,349 2,626
Earnings Before Interest and Tax 273,716 167,346 118,222 (3,551)
Interest Expense 61,651 55,518 32,121 20,652
Earnings Before Tax 212,065 111,828 86,101 (24,203)
Income Tax 69,031 47,582 (1,298) 2,858
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations 143,034 48,666 87,399 (27,061)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income 143,034 64,246 87,399 (27,061)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders 143,034 64,246 87,399 (27,061)
Salix Pharmaceuticals, Ltd.
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue 933,838 735,444 540,488 336,973
Cost of Revenue 179,392 124,597 95,369 68,677
Gross Profit 754,446 610,847 445,119 268,296
Operating Expenses
Research and Development 149,974 123,234 104,350 73,346
Sales, General and Admin. 288,015 228,589 213,988 156,101
Non-Recurring Items - 41,600 - 34,656
Other 44,744 45,351 10,908 10,370
Operating Income 271,713 172,073 115,873 (6,177)
Income From Continuing Operations
Add'l Income/Expense Items 2,003 (4,727) 2,349 2,626
Earnings Before Interest and Tax 273,716 167,346 118,222 (3,551)
Interest Expense 61,651 55,518 32,121 20,652
Earnings Before Tax 212,065 111,828 86,101 (24,203)
Income Tax 69,031 47,582 (1,298) 2,858
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations 143,034 48,666 87,399 (27,061)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income 143,034 64,246 87,399 (27,061)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders 143,034 64,246 87,399 (27,061)
